V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006491 | 300004594 | 1.57 | null | Curative (C) | 2014-05-19 | 2014-05-22 | DAIICHI Trial | N | N | 300016860 | GEMCARBO |
| 300006492 | 300006901 | 1.62 | 52.7 | Curative (C) | 2018-12-20 | 2019-02-07 | Irinotecan + Modified De Gramont | Y | N | 300016876 | BEVACIZUMAB |
| 300006493 | 300004596 | null | 80.5 | Neo-adjuvant (N) | 2017-03-16 | 2017-04-06 | EOX | 2 | N | 300016877 | NIVOLUMAB |
| 300006494 | 300004597 | 1.63 | 63.2 | Curative (C) | 2014-03-23 | 2014-03-28 | DE-ESCALATE TRIAL | N | null | 300016877 | CETUXIMAB + RT |
| 300006495 | 300004598 | 1.57 | null | Palliative (P) | null | 2016-05-05 | Oxaliplatin + Modified de Gramont | null | null | 300016886 | CAPECITABINE + GEMCITABINE |
| 300006496 | 300004599 | 1.64 | 65.1 | Palliative (P) | 2013-06-04 | 2013-06-19 | Carboplatin AUC 6 - 10 | N | null | 300016896 | CARBOPLATIN + RT |
| 300006497 | 300004600 | 1.45 | null | Curative (C) | 2017-07-04 | 2017-07-05 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 300016908 | CISPLATIN + FLUOROURACIL |
| 300006498 | 300004601 | 1.67 | 85 | null | 2017-11-21 | 2018-01-15 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 300016929 | TRIAL |
| 300006499 | 300006904 | 1.69 | 98 | null | 2015-07-26 | 2015-08-03 | Capecitabine | 2 | N | 300016941 | GEMCARBO |
| 300006500 | 300004603 | 1.7 | 72 | Palliative (P) | null | 2015-02-21 | NIVOLUMAB | N | Y | 300016941 | CETUXIMAB |
| 300006501 | 300004604 | 1.67 | 76.2 | Curative (C) | 2013-06-24 | 2013-07-16 | CETUXIMAB | 02 | Y | 300016974 | CISPLATIN |
| 300006502 | 300004605 | 1.55 | 54.2 | Palliative (P) | 2015-05-17 | 2015-06-08 | Cisplatin | N | Y | 300016978 | CETUXIMAB |
| 300006503 | 300004607 | null | 98.8 | Curative (C) | 2014-06-18 | 2014-06-26 | CISPLATIN + FLUOROURACIL | 2 | N | 300016978 | CAPECITABINE |
| 300006504 | 300004607 | 1.92 | 65.8 | Neo-adjuvant (N) | 2015-04-14 | 2015-04-15 | Cisplatin | 02 | Y | 300016978 | CISPLATIN + FLUOROURACIL + RT |
| 300006505 | 300004609 | null | null | Palliative (P) | 2014-07-01 | 2014-07-20 | Oxaliplatin + Modified de Gramont | N | N | 300017001 | GEMCARBO |
| 300006506 | 300004610 | 1.58 | 58.9 | null | null | 2016-04-03 | Trial Unspecified | null | null | 300017004 | TRIAL |
| 300006507 | 300004611 | 1.59 | 44.6 | null | 2015-11-09 | 2015-11-18 | GEMCARBO | N | N | 300017004 | CETUXIMAB |
| 300006508 | 300004612 | 1.68 | 45 | Neo-adjuvant (N) | 2016-05-12 | 2016-05-27 | Cisplatin | 2 | N | 300017012 | CAPECITABINE + GEMCITABINE |
| 300006509 | 300004613 | 1.58 | 60.6 | Neo-adjuvant (N) | 2015-09-26 | 2015-10-04 | Carbo F | N | N | 300017014 | NIVOLUMAB |
| 300006510 | 300004613 | 1.7 | 111 | Palliative (P) | 2017-01-25 | 2017-02-03 | CARBOPLATIN + PACLITAXEL | 02 | null | 300017014 | ESPAC TRIAL |
| 300006511 | 300004614 | 1.73 | 118.5 | Neo-adjuvant (N) | 2013-04-24 | 2013-05-08 | Gemcitabine + Capecitabine | Y | N | 300017019 | DAIICHI TRIAL |
| 300006512 | 300004615 | 1.72 | 69 | Neo-adjuvant (N) | 2016-08-22 | 2016-09-05 | Paclitaxel albumin (Abraxane) 7 day | N | N | 300017026 | NIVOLUMAB |
| 300006513 | 300004616 | null | 74.9 | Adjuvant (A) | 2014-12-19 | 2015-02-27 | CAV | 02 | N | 300017026 | CISPLATIN + FLUOROURACIL |
| 300006514 | 300004617 | 1.7 | 85.2 | Curative (C) | 2014-08-10 | 2014-08-11 | Carboplatin AUC 6 - 10 | N | Y | 300017033 | CISPLATIN |
| 300006515 | 300004618 | 1.72 | 63.2 | null | 2017-02-02 | 2017-03-23 | Trial Unspecified | 02 | N | 300017043 | CAPECITABINE + OXALIPLATIN |
| 300006516 | 300004619 | 1.5 | null | Curative (C) | 2013-08-23 | 2013-08-23 | KESTREL Trial | 02 | N | 300017054 | GEMCARBO |
| 300006517 | 300006914 | 1.8 | 64.6 | Palliative (P) | 2017-06-27 | 2017-09-14 | Trial Unspecified | 02 | N | 300017069 | OXALIPLATIN + MDG |
| 300006518 | 300004620 | 1.59 | 53.5 | Neo-adjuvant (N) | 2017-09-05 | 2017-09-27 | null | 2 | N | 300017071 | CAPECITABINE |
| 300006519 | 300004621 | null | 65.4 | Curative (C) | 2016-03-16 | 2016-03-16 | EOX | N | N | 300017073 | CAPECITABINE + CARBOPLATIN |
| 300006520 | 300004622 | 1.7 | 57 | Curative (C) | 2017-04-12 | 2017-04-12 | MITOTANE | N | N | 300017075 | GEMCITABINE + NAB-PACLITAXEL |
| 300006521 | 300004623 | 1.52 | null | null | 2015-11-22 | 2015-11-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300017078 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006522 | 300004624 | 1.79 | 68.9 | Palliative (P) | null | 2017-02-02 | FLUOROURACIL + OXALIPLATIN | null | null | 300017080 | CETUXIMAB |
| 300006523 | 300004625 | 1.7 | 56.3 | Palliative (P) | 2019-04-04 | 2019-04-05 | GEMCARBO | N | N | 300017081 | HYDROXYCARBAMIDE |
| 300006524 | 300004627 | 1.83 | 51.45 | null | 2016-12-01 | 2017-01-10 | OXALIPLATIN | Y | null | 300017081 | TRIAL |
| 300006525 | 300004630 | 1.77 | 18 | Palliative (P) | 2013-06-26 | 2013-07-06 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 300017099 | CARBOPLATIN + CETUXIMAB + FU |
| 300006526 | 300004631 | null | 73.45 | Neo-adjuvant (N) | 2012-11-27 | 2015-01-06 | Folfirinox | N | N | 300017099 | GEMCARBO |
| 300006527 | 300004632 | 1.64 | 82 | Curative (C) | 2014-01-19 | 2014-01-27 | Cetuximab + Radiotherapy Maint | 02 | Y | 300017103 | CARBOPLATIN + RT |
| 300006528 | 300004635 | 1.78 | 94.1 | null | 2017-05-06 | 2017-06-18 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300017106 | CETUXIMAB |
| 300006529 | 300004639 | 1.67 | 46 | Neo-adjuvant (N) | 2014-08-30 | 2014-08-30 | Oxaliplatin + Modified de Gramont | 02 | N | 300017108 | TEMOZOLOMIDE |
| 300006530 | 300007765 | 1.69 | 68.9 | Curative (C) | 2014-09-02 | 2014-10-06 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300017109 | CARBOPLATIN |
| 300006531 | 300007765 | null | 56.4 | Curative (C) | 2014-11-01 | 2014-11-28 | Alemtuzumab + Cyclophos TBI Allo | N | Y | 300017109 | CAPECITABINE + RT |
| 300006532 | 300004641 | 1.63 | 49.2 | Curative (C) | 2015-11-20 | 2015-11-26 | Trial Unspecified | 02 | null | 300017110 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 300006533 | 300004642 | 1.83 | null | Palliative (P) | 2017-06-05 | 2017-08-04 | CARBOPLATIN + RT | N | Y | 300017117 | CETUXIMAB |
| 300006534 | 300006920 | 1.74 | null | Curative (C) | 2015-08-16 | 2015-08-31 | Cisplatin | 02 | N | 300017117 | NOT MATCHED |
| 300006535 | 300004643 | 1.6 | 56.1 | null | 2017-04-13 | 2017-04-28 | Cisplatin | Y | N | 300017132 | PACLITAXEL |
| 300006536 | 300004644 | 1.67 | null | Palliative (P) | 2017-01-21 | 2017-01-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017148 | CISPLATIN + FLUOROURACIL |
| 300006537 | 300004645 | 1.55 | 74.7 | Neo-adjuvant (N) | 2014-07-17 | 2014-07-17 | Folfirinox | 02 | N | 300017149 | CARBOPLATIN |
| 300006538 | 300004647 | null | 68 | Palliative (P) | 2016-12-15 | 2017-02-10 | CISPLATIN + FLUOROURACIL | 02 | N | 300017151 | CARBOPLATIN + ETOPOSIDE |
| 300006539 | 300004649 | 1.76 | 0 | Neo-adjuvant (N) | 2014-07-24 | 2014-07-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300017160 | CARBO + FLUOROURACIL |
| 300006540 | 300004650 | null | 65.8 | Curative (C) | null | 2017-07-17 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017162 | CETUXIMAB |